DNA repair pathways, full network

Pathway network for the DNA repair pathways, full network SuperPath

Sources:
  • WikiPathways
  • Reactome
  • QIAGEN

Pathways in the DNA repair pathways, full network SuperPath

#NameSourceGenes
1DNA repair pathways, full networkWikiPathways
2Nucleotide excision repair in xeroderma pigmentosumWikiPathways
3Nucleotide excision repairWikiPathways
4Dual Incision in GG-NERReactome
5Nucleotide Excision Repair PathwayQIAGEN
6Mismatch RepairReactome
7Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)Reactome
8Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)Reactome
9Homologous recombinationWikiPathways
10Non-homologous end joiningWikiPathways
11Diseases of Mismatch Repair (MMR)Reactome
12Defective Mismatch Repair Associated With MSH2Reactome
13Defective Mismatch Repair Associated With MSH6Reactome
14Defective Mismatch Repair Associated With MSH3Reactome

Gene overlap in member pathways for DNA repair pathways, full network SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with DNA repair pathways, full network SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Breast cancerEnrichmentATM, BRCA1, BRCA2, BRIP1, FANCM, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, RAD50, RAD51, RAD51C16.00
2Colorectal cancerEnrichmentATM, BRCA1, BRCA2, BRIP1, FANCE, FANCI, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS2, POLD1, POLE, RAD54B, REV3L16.00
3Ovarian cancerEnrichmentATM, BRCA1, BRCA2, BRIP1, ERCC2, ERCC3, ERCC4, ERCC5, FANCA, FANCD2, FANCE, FANCG, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, RAD50, RAD51C, WRN, XPA, XPC16.00
4Fanconi anemia, complementation group aEnrichmentBRCA1, BRCA2, BRIP1, ERCC4, FANCA, FANCB, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, PALB2, RAD51, RAD51C16.00
5Pancreatic cancerEnrichmentATM, BRCA1, BRCA2, BRIP1, ERCC4, FANCE, FANCG, NBN, PALB2, POLD116.00
6Xeroderma pigmentosum, variant typeEnrichmentDDB2, ERCC2, ERCC3, ERCC4, ERCC5, POLH, XPA, XPC16.00
7Breast-ovarian cancer, familial 1EnrichmentATM, BRCA1, BRCA2, BRIP1, MSH2, NBN, PALB2, RAD51C16.00
8Gastric cancerEnrichmentATM, BRCA1, BRCA2, BRIP1, FANCI, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, RAD51C16.00
9Hereditary breast carcinomaEnrichmentATM, BRCA1, BRCA2, BRIP1, FANCM, MLH1, MSH2, MSH6, MUTYH, NBN, PALB2, RAD50, RAD5116.00
10Uterine corpus cancerEnrichmentATM, BRCA1, BRCA2, BRIP1, MSH2, MSH6, PALB2, RAD51C16.00
11Inherited cancer-predisposing syndromeEnrichmentATM, BRCA1, BRCA2, BRIP1, ERCC3, FANCA, FANCM, MBD4, MLH1, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NTHL1, PALB2, PMS2, POLD1, POLE, RAD50, RAD51C16.00
12Lynch syndrome 1EnrichmentMLH1, MSH2, MSH6, PMS211.70
13Hereditary breast ovarian cancer syndromeEnrichmentATM, BRCA1, BRCA2, BRIP1, FANCM, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS2, RAD50, RAD51, RAD51C11.64
14Endometrial cancerEnrichmentATM, BRCA1, BRCA2, MLH1, MSH2, MSH3, MSH6, MUTYH, PMS2, RAD51C11.44
15Mismatch repair cancer syndrome 1EnrichmentMLH1, MSH2, MSH6, PMS210.68
16Lynch syndromeEnrichmentMLH1, MSH2, MSH6, PMS210.44
17Lynch syndrome 4EnrichmentMSH2, MSH6, PMS29.91
18Xeroderma pigmentosum-cockayne syndrome complexEnrichmentERCC2, ERCC3, ERCC4, ERCC59.42
19Cerebrooculofacioskeletal syndrome 1EnrichmentERCC1, ERCC2, ERCC5, ERCC68.88
20Prostate cancerEnrichmentATM, BRCA1, BRCA2, MSH6, NBN, PALB2, POLK8.35
21Colonic benign neoplasmEnrichmentATM, MLH1, MRE11, MUTYH, PALB28.23
22RhabdomyosarcomaEnrichmentMSH2, MSH6, PMS27.87
23Familial colorectal cancer type xEnrichmentATM, BRCA2, MUTYH, POLD1, POLE7.67
24Uv-sensitive syndromeEnrichmentERCC6, ERCC8, UVSSA7.22
25Cockayne syndrome aEnrichmentERCC4, ERCC6, ERCC87.10
26Muir-torre syndromeEnrichmentMLH1, MSH26.96
27Cockayne syndrome bEnrichmentERCC1, ERCC6, ERCC86.80
28Cockayne syndromeEnrichmentERCC4, ERCC6, ERCC86.56
29Lig4 syndromeEnrichmentLIG4, XRCC46.31
30HepatoblastomaEnrichmentBRCA2, ERCC2, ERCC5, FANCA, MSH26.06
31Severe combined immunodeficiencyEnrichmentDCLRE1C, LIG4, NHEJ15.81
32TrichothiodystrophyEnrichmentERCC2, ERCC3, GTF2H55.67
33Xeroderma pigmentosum, complementation group aEnrichmentXPA, XPC5.39
34Cockayne syndrome type 3EnrichmentERCC6, ERCC85.39
35Familial colorectal cancerEnrichmentMLH1, MSH25.31
36Nijmegen breakage syndrome-like disorderEnrichmentMRE11, RAD505.29
37Breast-ovarian cancer, familial 2EnrichmentBRCA1, BRCA2, PMS25.19
38Polymerase proofreading-related polyposisEnrichmentPOLD1, POLE4.91
39Omenn syndromeEnrichmentDCLRE1C, LIG44.66
40Diffuse midline glioma, h3 k27m-mutantEnrichmentBRCA2, BRIP14.12
41Inflammatory breast carcinomaEnrichmentBRCA1, BRCA24.12
42Bilateral breast cancerEnrichmentBRCA1, BRCA24.12
43Neuroendocrine tumor of pancreasEnrichmentBRCA2, PALB24.12
44Bladder cancerEnrichmentATM, BRCA1, BRCA2, ERCC23.95
45Diffuse large b-cell lymphomaEnrichmentBRCA2, NBN3.84
46Mismatch repair cancer syndrome 2EnrichmentMSH23.83
47Rectal benign neoplasmEnrichmentMSH23.83
48Ascending colon cancerEnrichmentMSH23.83
49Ovarian cystEnrichmentMSH23.83
50Lung cancerEnrichmentBRCA1, ERCC6, MLH1, PALB23.78
51Hepatocellular carcinomaEnrichmentNBN, RAD503.71
52Mismatch repair cancer syndrome 3EnrichmentMSH63.53
53GliosarcomaEnrichmentATM, MGMT, MSH23.47
54Lynch syndrome 2EnrichmentMLH13.43
55Mismatch repair cancer syndrome 4EnrichmentPMS23.43
56Pituitary cancerEnrichmentPMS23.43
57Giant cell glioblastomaEnrichmentATM, MGMT, MSH23.39
58Lynch syndrome 5EnrichmentMSH63.35
59Cellular ependymomaEnrichmentMSH23.35
60Tanycytic ependymomaEnrichmentMSH23.35
61Papillary ependymomaEnrichmentMSH23.35
62Intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesEnrichmentMSH63.35
63Colon adenocarcinomaEnrichmentMSH63.35
64Clear cell ependymomaEnrichmentMSH23.35
65Familial adenomatous polyposis 4EnrichmentMSH33.35
66Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemiaEnrichmentMRE11, PNKP3.34
67ChordomaEnrichmentBRCA2, PALB23.34
68Polyposis syndrome, hereditary mixed, 1EnrichmentBRCA1, BRCA23.34
69CholangiocarcinomaEnrichmentBRCA1, BRCA23.34
70Gaucher disease, type iEnrichmentMSH63.23
71Benign ependymomaEnrichmentMSH23.23
72Burkitt lymphomaEnrichmentPMS23.13
73GlioblastomaEnrichmentMSH23.13
74Immunodeficiency 124, severe combinedEnrichmentNHEJ13.13
75Immunodeficiency 26 with or without neurologic abnormalitiesEnrichmentPRKDC3.13
76Microphthalmia/coloboma 13EnrichmentNHEJ13.13
77Fanconi anemia, complementation group d2EnrichmentBRIP1, FANCD23.12
78Colorectal cancer 10EnrichmentPOLD13.02
79Glioma susceptibility 3EnrichmentBRCA23.02
80Mirror movements 2EnrichmentRAD513.02
81Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6EnrichmentRPA13.02
82Fanconi anemia, complementation group rEnrichmentRAD513.02
83Immunodeficiency 120EnrichmentPOLD13.02
84Pancreatic cancer 2EnrichmentBRCA23.02
85Ataxia-telangiectasia-like disorder 1EnrichmentMRE113.02
86Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndromeEnrichmentPOLD13.02
87Endometrial serous adenocarcinomaEnrichmentATM3.02
88Immunodeficiency 122EnrichmentPOLD33.02
89B-cell non-hodgkin lymphomaEnrichmentATM3.02
90Ataxia-telangiectasia-like disorder 2EnrichmentPCNA2.99
91Immunodeficiency 96EnrichmentLIG12.99
92Clear cell renal cell carcinomaEnrichmentATM, OGG12.95
93Myeloma, multipleEnrichmentATM, BRCA22.90
94Chromosome 2q35 duplication syndromeEnrichmentNHEJ12.83
95Dubowitz syndromeEnrichmentLIG42.83
96Severe combined immunodeficiency with sensitivity to ionizing radiationEnrichmentDCLRE1C2.83
97Werner syndromeEnrichmentWRN2.83
98Short stature, microcephaly, and endocrine dysfunctionEnrichmentXRCC42.83
99Microcephalic primordial dwarfism-insulin resistance syndromeEnrichmentXRCC42.83
100Primary ovarian insufficiencyEnrichmentERCC1, FANCA, NBN, RAD51C2.75
101LymphomaEnrichmentPMS22.73
102Cardiac valvular dysplasia, x-linkedEnrichmentATM2.72
103High grade gliomaEnrichmentATM2.72
104Fanconi anemia, complementation group d1EnrichmentBRCA22.72
105T-cell prolymphocytic leukemiaEnrichmentATM2.72
106Cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and impaired intellectual developmentEnrichmentPOLE2.69
107Cerebrooculofacioskeletal syndrome 4EnrichmentERCC12.69
108Colorectal cancer 12EnrichmentPOLE2.69
109Leukodystrophy, hypomyelinating, 27EnrichmentPOLR1A2.69
110Xfe progeroid syndromeEnrichmentERCC42.69
111Morimoto-ryu-malicdan neuromuscular syndromeEnrichmentRFC42.69
112Isolated growth hormone deficiency, type iaEnrichmentBRCA2, XRCC42.69
113Ehlers-danlos syndrome, kyphoscoliotic type, 1EnrichmentDCLRE1C2.66
114Plod1-related kyphoscoliotic ehlers-danlos syndromeEnrichmentDCLRE1C2.66
115Isolated anophthalmia-microphthalmia syndromeEnrichmentNHEJ12.66
116Tracheoesophageal fistula with or without esophageal atresiaEnrichmentBRCA2, BRIP12.58
117Leukemia, acute lymphoblastic 3EnrichmentERCC4, PALB22.58
118Ataxia-telangiectasiaEnrichmentATM2.54
119Nijmegen breakage syndromeEnrichmentNBN2.54
120Polycythemia veraEnrichmentATM2.54
121Tumor predisposition syndrome 1EnrichmentBRCA22.54
122Koolen-de vries syndromeEnrichmentATM2.54
123AdenocarcinomaEnrichmentATM2.54
124Bap1 tumor predisposition syndromeEnrichmentBRCA22.54
125Aicardi-goutieres syndrome 1EnrichmentDCLRE1C2.53
126Xeroderma pigmentosum, complementation group bEnrichmentERCC32.52
127White-kernohan syndromeEnrichmentDDB12.52
128Xeroderma pigmentosum, complementation group dEnrichmentERCC22.52
129Trichothiodystrophy 2, photosensitiveEnrichmentERCC32.52
130Xeroderma pigmentosum group bEnrichmentERCC32.52
131Cerebrooculofacioskeletal syndrome 2EnrichmentERCC22.52
132Trichothiodystrophy 3, photosensitiveEnrichmentGTF2H52.52
133Xeroderma pigmentosum group dEnrichmentERCC22.52
134Isolated tracheo-esophageal fistulaEnrichmentBRCA2, BRIP12.48
135Mirror movements 1EnrichmentRAD512.42
136Mantle cell lymphomaEnrichmentATM2.42
137Oculomotor apraxiaEnrichmentATM2.42
138Palmoplantar keratoderma, punctate type iiEnrichmentBRCA12.40
139Fanconi anemia, complementation group pEnrichmentSLX42.40
140Infant-type hemispheric gliomaEnrichmentBRCA12.40
141Uv-sensitive syndrome 3EnrichmentUVSSA2.40
142Spinocerebellar ataxia, autosomal recessive 26EnrichmentXRCC12.40
143Primary peritoneal carcinomaEnrichmentBRCA12.40
144Cardiomyopathy, familial hypertrophic, 9EnrichmentPMS22.39
145Xeroderma pigmentosum, complementation group fEnrichmentERCC42.38
146Xeroderma pigmentosum, complementation group cEnrichmentXPC2.38
147Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomaliesEnrichmentPOLE2.38
148Cerebellar ataxia, neuropathy, and vestibular areflexia syndromeEnrichmentRFC12.38
149Mitochondrial complex i deficiency, nuclear type 10EnrichmentERCC82.38
150Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiencyEnrichmentPOLE2.38
151Fanconi anemia, complementation group qEnrichmentERCC42.38
152Xeroderma pigmentosum group fEnrichmentERCC42.38
153Facial dysmorphism, immunodeficiency, livedo, and short statureEnrichmentPOLE2.38
154Acrofacial dysostosis, cincinnati typeEnrichmentPOLR1A2.38
155Xeroderma pigmentosum group cEnrichmentXPC2.38
156Mitochondrial dna depletion syndrome 20EnrichmentLIG32.38
157Premature menopauseEnrichmentERCC1, NBN2.25
158Kabuki syndrome 1EnrichmentBRCA22.24
159Xeroderma pigmentosum, complementation group eEnrichmentDDB22.22
160Intellectual developmental disorder, x-linked, syndromic, cabezas typeEnrichmentCUL4B2.22
161Neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic faciesEnrichmentPOLK2.22
162Pettigrew syndromeEnrichmentCUL4B2.22
163Xeroderma pigmentosum group eEnrichmentDDB22.22
164Submucosal cleft palateEnrichmentUBB2.22
165Cleft hard palateEnrichmentUBB2.22
166De sanctis-cacchione syndromeEnrichmentERCC62.21
167Xeroderma pigmentosum, complementation group gEnrichmentERCC52.21
168Burn-mckeown syndromeEnrichmentPOLR1A2.21
169Uv-sensitive syndrome 1EnrichmentERCC62.21
170Uv-sensitive syndrome 2EnrichmentERCC82.21
171Cerebrooculofacioskeletal syndrome 3EnrichmentERCC52.21
172Premature ovarian failure 11EnrichmentERCC62.21
173Childhood apraxia of speechEnrichmentRFC32.21
174Xeroderma pigmentosum group gEnrichmentERCC52.21
175MedulloblastomaEnrichmentBRCA2, WRN2.19
176Pituitary stalk interruption syndromeEnrichmentFANCA, FANCG2.19
177Renal cell carcinoma, papillary, 1EnrichmentATM2.17
178Renal cell carcinoma, nonpapillaryEnrichmentATM, OGG12.13
179Lymphoma, non-hodgkin, familialEnrichmentRAD54B2.12
180Fanconi anemia, complementation group sEnrichmentBRCA12.10
181Pancreatic cancer 4EnrichmentBRCA12.10
182Hao-fountain syndromeEnrichmentUSP72.10
183Peritoneum cancerEnrichmentBRCA12.10
184Cardiomyopathy, dilated, 1gEnrichmentPMS22.09
185Hutchinson-gilford progeria syndromeEnrichmentERCC42.08
186Deafness, autosomal recessive 1aEnrichmentERCC82.08
187Macular degeneration, age-related, 5EnrichmentERCC62.08
188Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalitiesEnrichmentPOLR2A2.08
189Gjb2-related autosomal recessive nonsyndromic hearing lossEnrichmentERCC82.08
190PolydactylyEnrichmentBRCA22.07
191Fanconi anemia, complementation group jEnrichmentBRIP12.06
192Brachyphalangy, polydactyly, and tibial aplasia/hypoplasiaEnrichmentHMGB12.06
193Melanoma, uveal 1EnrichmentMBD42.06
194Ataxia-oculomotor apraxia 4EnrichmentPNKP2.06
195Seckel syndrome 1EnrichmentATR2.06
196Fanconi anemia, complementation group gEnrichmentFANCG2.06
197Fanconi anemia, complementation group bEnrichmentFANCB2.06
198Spermatogenic failure 28EnrichmentFANCM2.06
199Premature ovarian failure 15EnrichmentFANCM2.06
200Cutaneous telangiectasia and cancer syndrome, familialEnrichmentATR2.06
201Familial adenomatous polyposis 3EnrichmentNTHL12.06
202Fanconi anemia, complementation group lEnrichmentFANCL2.06
203Autosomal recessive spastic paraplegia type 60EnrichmentWDR482.06
204Tumor predisposition syndrome 2EnrichmentMBD42.06
205Fanconi anemia, complementation group xEnrichmentFAAP1002.06
206Oocyte/zygote/embryo maturation arrest 21EnrichmentCHEK12.06
207Basal cell carcinomaEnrichmentPALB22.06
208Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndromeEnrichmentATR2.06
209Uvula, bifidEnrichmentUBB2.04
210Trichothiodystrophy 1, photosensitiveEnrichmentERCC22.04
211Cleft soft palateEnrichmentUBB2.04
212Wieacker-wolff syndromeEnrichmentCCNH2.02
213Leukemia, chronic lymphocyticEnrichmentATM2.02
214Aplastic anemiaEnrichmentNBN2.02
215CataractEnrichmentWRN1.99
216Autosomal recessive cerebellar ataxiaEnrichmentERCC41.99
217PolyneuropathyEnrichmentERCC51.99
218Immune deficiency diseaseEnrichmentATM1.98
219Leukemia, acute lymphoblasticEnrichmentNBN1.98
220Combined immunodeficiencyEnrichmentPOLD11.98
221Combined t cell and b cell immunodeficiencyEnrichmentPOLD11.98
222Combined t and b cell immunodeficiencyEnrichmentPOLD11.98
223Esophageal atresia/tracheoesophageal fistulaEnrichmentBRCA2, BRIP11.93
224CraniopharyngiomaEnrichmentERCC21.92
225Wilms tumor 1EnrichmentBRCA21.85
226Capillary malformations, congenitalEnrichmentCCNH1.80
227Ovarian germ cell cancerEnrichmentFANCM1.76
228Vacterl association, x-linked, with or without hydrocephalusEnrichmentFANCL1.76
229Fanconi anemia, complementation group iEnrichmentFANCI1.76
230Fanconi anemia, complementation group nEnrichmentPALB21.76
231Familial adenomatous polyposis 2EnrichmentMUTYH1.76
232Charcot-marie-tooth disease, axonal, type 2b2EnrichmentPNKP1.76
233Pancreatic cancer 3EnrichmentPALB21.76
234Ovarian cancer 1EnrichmentBRIP11.76
235Interstitial nephritis, karyomegalicEnrichmentFAN11.76
236Intellectual developmental disorder, x-linked, syndromic, pilorge typeEnrichmentFANCB1.76
237Fanconi anemia, complementation group eEnrichmentFANCE1.76
238Charcot-marie-tooth disease type 2b2EnrichmentPNKP1.76
239Microcephaly, seizures, and developmental delayEnrichmentPNKP1.76
240Immunodeficiency with hyper-igm, type 5EnrichmentUNG1.76
241Vacterl with hydrocephalusEnrichmentFANCB1.76
242Malignant germ cell tumor of ovaryEnrichmentFANCM1.76
243Mitochondrial neurogastrointestinal encephalomyopathyEnrichmentLIG31.73
244Klippel-trenaunay-weber syndromeEnrichmentCCNH1.72
245Telangiectasia, hereditary hemorrhagic, type 1EnrichmentCCNH1.72
246Hemangioma, capillary infantileEnrichmentCCNH1.72
247Basal cell carcinoma 1EnrichmentCCNH1.72
248LissencephalyEnrichmentNBN1.70
249Capillary malformation-arteriovenous malformation 1EnrichmentCCNH1.66
250Hereditary hemorrhagic telangiectasiaEnrichmentCCNH1.66
251Pectus excavatumEnrichmentERCC51.65
252RetinoblastomaEnrichmentFANCM1.58
253Spastic paraplegia 7, autosomal recessiveEnrichmentMUTYH1.58
254Breast-ovarian cancer, familial 3EnrichmentRAD51C1.58
255Fanconi anemia, complementation group oEnrichmentRAD51C1.58
256Breast-ovarian cancer, familial 5EnrichmentPALB21.58
257Fanconi anemia, complementation group fEnrichmentFANCF1.58
258Hereditary site-specific ovarian cancer syndromeEnrichmentRAD51C1.58
259Inflammatory bowel disease 1EnrichmentERCC21.57
260Hypotrichosis simplexEnrichmentERCC21.57
261Arteriovenous malformationEnrichmentCCNH1.55
262Type 2 diabetes mellitusEnrichmentWRN1.52
263Myopathy, x-linked, with excessive autophagyEnrichmentCCNH1.50
264Erythrocytosis, familial, 2EnrichmentFANCD21.46
265PilomatrixomaEnrichmentMUTYH1.46
266Developmental and epileptic encephalopathy 12EnrichmentPNKP1.46
267Vacterl associationEnrichmentFANCL1.46
268Male infertility due to gonadal dysgenesis or sperm disorderEnrichmentCHEK11.46
269Cerebral palsyEnrichmentBRCA21.43
270Parkinson's diseaseEnrichmentRFC11.41
271Williams-beuren syndromeEnrichmentRFC21.39
272Moebius syndromeEnrichmentREV3L1.37
273Vater/vacterl associationEnrichmentFANCL1.37
274Von hippel-lindau syndromeEnrichmentFANCD21.37
275Familial adenomatous polyposis 1EnrichmentMUTYH1.37
276Corpus callosum, agenesis ofEnrichmentERCC21.35
277Isolated corpus callosum agenesisEnrichmentERCC21.35
278Intellectual disability-hypoplastic corpus callosum-preauricular tag syndromeEnrichmentERCC21.35
279Parkinson disease, late-onsetEnrichmentRFC11.31
280Periventricular nodular heterotopiaEnrichmentBRCA11.26
281LeukodystrophyEnrichmentERCC21.23
282Mitochondrial dna depletion syndrome 4aEnrichmentFANCI1.22
283Hereditary clear cell renal cell carcinomaEnrichmentOGG11.22
284Mitochondrial complex i deficiency, nuclear type 1EnrichmentERCC81.12
285Spastic ataxiaEnrichmentERCC40.98
286MicrocephalyEnrichmentNBN0.95
287Seckel syndromeEnrichmentATR0.94
288Male infertility with spermatogenesis disorderEnrichmentFANCM0.91
289Isolated congenital microcephalyEnrichmentPNKP0.88
290Melanoma, cutaneous malignant 1EnrichmentMGMT0.86
291Early infantile developmental and epileptic encephalopathyEnrichmentPNKP0.83
292AzoospermiaEnrichmentFANCM0.79
293Congenital nervous system abnormalityEnrichmentERCC80.70
294Nervous system diseaseEnrichmentERCC80.70
295Leukemia, acute myeloidEnrichmentFANCD20.53
296Male infertility with azoospermia or oligozoospermia due to single gene mutationEnrichmentFANCM0.41

Loading...
Loading...
Loading...